Clinical Research Directory
Browse clinical research sites, groups, and studies.
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
Sponsor: Aptinyx
Summary
A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia
Official title: A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia
Key Details
Gender
All
Age Range
50 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
99
Start Date
2019-11-14
Completion Date
2022-12-30
Last Updated
2022-10-27
Healthy Volunteers
No
Interventions
Placebo Oral Capsule
Matching placebo capsules.
NYX-458
NYX-458 is a small molecule that modulates the N-methyl-D-aspartate receptor (NMDAR).
Locations (26)
Aptinyx Clinical Site
Scottsdale, Arizona, United States
Aptinyx Clinical Site
Fresno, California, United States
Aptinyx Clinical Site
Simi Valley, California, United States
Aptinyx Clinical Site
Boca Raton, Florida, United States
Aptinyx Clinical Site
Bradenton, Florida, United States
Aptinyx Clinical Site
Miami, Florida, United States
Aptinyx Clinical Site
Miami, Florida, United States
Aptinyx Clinical Site
Miami, Florida, United States
Aptinyx Clinical Site
Miami, Florida, United States
Aptinyx Clinical Site
Miami Lakes, Florida, United States
Aptinyx Clinical Site
Orlando, Florida, United States
Aptinyx Clinical Site
Port Charlotte, Florida, United States
Aptinyx Clinical Site
Port Orange, Florida, United States
Aptinyx Clinical Site
Sunrise, Florida, United States
Aptinyx Clinical Site
Decatur, Georgia, United States
Aptinyx Clinical Site
Farmington Hills, Michigan, United States
Aptinyx Clinical Site
Golden Valley, Minnesota, United States
Aptinyx Clinical Site
Toms River, New Jersey, United States
Aptinyx Clinical Site
Poughkeepsie, New York, United States
Aptinyx Clinical Site
Asheville, North Carolina, United States
Aptinyx Clinical Site
Dayton, Ohio, United States
Aptinyx Clinical Site
Tulsa, Oklahoma, United States
Aptinyx Clinical Site
Round Rock, Texas, United States
Aptinyx Clinical Site
Sugar Land, Texas, United States
Aptinyx Clinical Site
Bellevue, Washington, United States
Aptinyx Clinical Site
Spokane, Washington, United States